StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories scope 1+2 GHG Emissions — Diagnostics Division (ktCO2e)

Abbott Global Sustainability Reports (2022–2024)

Latest, FY2024
96
Period ended Dec 31, 2024
Change on a year earlier
-11.9%
109 in FY2023
History
7 years
Since FY2018
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedScope 1+2 GHG Emissions — Diagnostics Division (ktCO2e)Year on yearSource
FY2024Dec 31, 202496-11.9%Abbott 2024 Global Sustainability Report ↗
FY2023Dec 31, 2023109-10.7%Abbott 2024 Global Sustainability Report ↗
FY2022Dec 31, 2022122+10.9%Abbott 2024 Global Sustainability Report ↗
FY2021Dec 31, 2021110+10.0%Abbott 2022 Global Sustainability Report ↗
FY2020Dec 31, 2020100+3.1%Abbott 2022 Global Sustainability Report ↗
FY2019Dec 31, 2019970.0%Abbott 2022 Global Sustainability Report ↗
FY2018Dec 31, 201897–Abbott 2022 Global Sustainability Report ↗

Cite this data

StockData. (2026). Abbott Laboratories Scope 1+2 GHG Emissions — Diagnostics Division (ktCO2e), annual FY2018–FY2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/esg-ghg-div-dx

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.